INC 41540 REINSTATED ON 100517~(All Except USA)

FSC Information

6505	Drugs and Biologicals

Colloquial Information

No Colloquials assigned to this Approve Item Name at this time

Change List

NAMEDITEM NAME

NOUN, WITH OR WITHOUT MODIFIERS, BY WHICH AN ITEM OF SUPPLY IS KNOWN.

Enter the item name code.

(NAMED41540*)

CQCTDPRIMARY CONTAINER TYPE

INDICATES THE TYPE OF CONTAINER/S/ OR SUPPORTING DEVICE/S/ WHICH IS IN DIRECT CONTACT WITH THE ITEM.

Enter the applicable reply code from the table below

(CQCTDAEY)

Table 1
	Reply Code (AN65)	Reply
	ARP	APPLICATOR BOTTLE
	AAK	BOTTLE
	ABW	BOTTLE WITH DISPENSER CAP
	ARQ	BOTTLE WITH DISPENSER TIP
	ARR	BOTTLE WITH DROPPER TIP
	AGE	BOTTLE WITH FLIP-TOP CLOSURE
	ABF	BOTTLE, PLASTIC
	ABK	BOTTLE, PLASTIC SQUEEZE
	AFR	TUBE
	AGB	TUBE WITH SCREW CAP
	AEY	TUBE, PLASTIC SQUEEZE

CRLKJPRIMARY CONTAINER CONTENT QUANTITY

A NUMERIC VALUE OF THE VOLUME,FORM,OR DOSAGE WITHIN EACH PRIMARY CONTAINER.

Enter the applicable Reply Code from Table 1 below followed by a numeric reply with a minimum of one digit, a decimal and a minimum of one digit.

(CRLKJLT2.0*)

Table 1
	Reply Code (AN64)	Reply
	FZ	FLUID OUNCES
	GM	GRAMS
	LT	LITERS
	ML	MILLILITERS
	OZ	OUNCES

CSGSDADMINISTRATION

THE AREA, ORIFICE, OR TISSUE OF THE BODY TO WHICH THE MEDICATION IS ADMINISTERED OR APPLIED BASED ON THE DRUG FORMULATION.

Enter the applicable reply code from the table below

(CSGSDAP)

Table 1
	Reply Code (AG60)	Reply
	AP	TOPICAL

CYMG*JACTIVE INGREDIENT AND STRENGTH

THE ACTIVE INDREDIENT(S) AND STRENGTH IN A PHARMACEUTICAL PREPARATION RECOGNIZED AS HAVING THERAPEUTIC VALUE(S).

Enter the applicable Reply Code from Tables 1 & 2 below followed by a numeric reply with a minimum of one digit, a decimal and a minimum of one digit.

(CYMGJB0025BD2.0*;CYMGJB0025BD2.0$$JB0025BD2.1*;CYMGJB0025BD2.0$JB0025BD2.0*)

Table 1
	Reply Code (AG54)	Reply
	B3684	AMCINONIDE
	A0521	AMINOBENZOIC ACID
	A0658	AMMONIUM LACTATE
	A0725	AMPHOTERICIN B
	A1419	BENZOYL PEROXIDE
	A1433	BENZYL BENZOATE
	B3374	BETAMETHASONE DIPROPIONATE
	B1670	BETAMETHASONE VALERATE
	A1984	CALAMINE
	A2140	CAMPHOR
	B4165	CARBAMIDE
	A2508	CHLORHYDROXYQUINOLIN
	B3433	CICLOPIROX OLAMINE
	B3739	CLOBETASOL PROPIONATE
	A5104	CLOTRIMAZOLE
	A3110	CROTAMITON
	A3712	DIHYDROXYACETONE
	B1291	DIISOPROPYL SEBACATE
	A3848	DIPHENHYDRAMINE HYDROCHLORIDE
	B3452	FLURANDRENOLIDE
	A5201	HEXACHLOROPHENE
	A5337	HYDROCORTISONE
	A5338	HYDROCORTISONE ACETATE
	A5745	ISOPROPYL ALCOHOL
	A5914	LACTIC ACID
	B4258	LANOLIN OIL
	A6115	LINDANE
	A6356	MALATHION
	A6533	MENTHOL
	A6765	METHOXSALEN
	A6898	METHYL SALICYLATE
	B3464	MICONAZOLE NITRATE
	A6944	MINERAL OIL
	B1378	MINERAL OIL, LIGHT
	B4259	PARACHLOROMETAXYLENOL
	A8498	PRAMOXINE HYDROCHLORIDE
	A8503	PREDNISOLONE
	A8504	PREDNISOLONE ACETATE
	A8652	PROPYLENE GLYCOL
	B4260	RESORCIN ALCOHOL
	A9003	RESORCINOL
	A9149	SALICYLIC ACID
	A9601	SODIUM THIOSULFATE
	A9838	SULFACETAMIDE
	B0114	SULFUR
	B0025	TRIAMCINOLONE
	B0026	TRIAMCINOLONE ACETONIDE
	B0799	UREA

Table 2
	Reply Code (AG53)	Reply
	AT	PERCENTAGE, V/V
	AS	PERCENTAGE, W/V
	BK	PERCENTAGE, W/V EQUIVALENT PER GRAM
	BL	PERCENTAGE, W/V PER FLUID OUNCE
	AR	PERCENTAGE, W/W
	BD	PERCENTAGE, W/W EQUIVALENT

AKJM*DMEDICAMENT BASE TYPE

THE SUPPORTING OR CARRYING INGREDIENT/S/ OR METHOD WHICH HELPS TO PROMOTE EFFICIENT RELEASE AND/OR ABSORPTION INTO THE CIRCULATORY SYSTEM,SOOTHE SURFACE TISSUE,LOCAL EFFECT,STIMULATION TO PERISTALSIS,AND THE LIKE.

Enter the applicable reply code from the table below

(AKJMDAS*;AKJMDDA$$DBC*)

Table 1
	Reply Code (AG62)	Reply
	DA	EMULSION BASE
	BC	EMULSION BASE, OIL-IN-WATER
	BD	EMULSION BASE, WATER-IN-OIL
	AS	GLYCERIN
	CF	MINERAL OIL
	DB	PROPYLENE GLYCOL

ALCD*GUSAGE DESIGN

INDICATES THE DESIGNED USE OF THE ITEM.

Enter clear text.

(ALCDGCLEARTEXT)

CSCW*ATOTAL PRIMARY CONTAINER QUANTITY

THE NUMBER OF PRIMARY CONTAINERS WITHIN THE ITEM OF SUPPLY.

Enter the numeric reply with a minimum of one digit.

(CSCWA10*)

CBBL*DFEATURES PROVIDED

THOSE FEATURES,NOT OTHERWISE SPECIFIED,WHICH MAY BE REQUIRED FOR PROPER FUNCTIONING OF THE ITEM.

Enter the applicable reply code from the table below

(CBBLDDBF*;CBBLDAFM$$DAFM*)

Table 1
	Reply Code (AN47)	Reply
	DBF	CHILD RESISTANT CLOSURE
	AFM	STERILE

FEAT*GSPECIAL FEATURES

THOSE UNUSUAL OR UNIQUE CHARACTERISTICS OR QUALITIES OF AN ITEM NOT COVERED IN THE OTHER REQUIREMENTS AND WHICH ARE DETERMINED TO BE ESSENTIAL FOR IDENTIFICATION ON ONE OR MORE OTHER FUNCTIONS.

Enter the reply in clear text. Separate multiple replies with a semicolon.

(FEATGADJUSTABLE NOSE CLIP*; FEATGADJUSTABLE NOSE PIECE; DISPOSABLE*)

ZZZK*JSPECIFICATION/STANDARD DATA

THE DOCUMENT DESIGNATOR OF THE SPECIFICATION OR STANDARD WHICH ESTABLISHED THE ITEM OF SUPPLY.

Enter the applicable Reply Code from the table below, followed by the Commercial and Government Entity (CAGE) Code of the entity controlling the document, a dash, and the document designator. The agency that controls the limited coordination document must be preceded and followed by a slash following the designator. The word canceled or superseded must be preceded and followed by a slash for the designator. Professional and industrial association specifications/standards are differentiated from a manufacturer's specification in that the data has been coordinated and published by the professional and industrial association. Include amendments and revisions where applicable.

(ZZZKJT81337-30642B*;ZZZKJS81349-MIL-D-180 REV1/CANCELED/*;ZZZKJP80205-NAS1103*;ZZZKJS81349-MIL-C-1140C/CE/*;ZZZKJT81337-30642B$$JP80205-NAS1103*)

Table 1
	Reply Code (AN62)	Reply
	S	GOVERNMENT SPECIFICATION
	T	GOVERNMENT STANDARD
	D	MANUFACTURERS SOURCE CONTROL
	R	MANUFACTURERS SPECIFICATION
	N	MANUFACTURERS SPECIFICATION CONTROL
	M	MANUFACTURERS STANDARD
	B	NATIONAL STD/SPEC
	A	PROFESSIONAL/INDUSTRIAL ASSOCIATION SPECIFICATION
	P	PROFESSIONAL/INDUSTRIAL ASSOCIATION STANDARD

If the specification/standard cited in reply to MRC ZZZK is nondefinitive, reply to MRC ZZZT. This reply is the data which is not recorded in Segment C.

ZZZT*JNONDEFINITIVE SPEC/STD DATA

THE NUMBER, LETTER, OR SYMBOL INDICATING THE TYPE, STYLE, GRADE, CLASS, AND THE LIKE OF AN ITEM IN A NONIDENTIFYING SPECIFICATION OR STANDARD.

Enter the applicable Reply Code from the table below followed by the appropriate number, letter or symbol.

(ZZZTJTY1*; ZZZTJTY1$$JSTA*; ZZZTJTY1$JSTA*)

Table 1
	Reply Code (AD08)	Reply
	AL	ALLOY
	BE	ANNEALED
	AN	ANNEX
	AP	APPENDIX
	AC	APPLICABILITY CLASS
	AR	ARRANGEMENT
	AS	ASSEMBLY
	AB	ASSORTMENT
	BF	BOND
	BX	BOX
	CY	CAPACITY
	CA	CASE
	CT	CATEGORY
	CF	CIRCUMFERENCE
	CL	CLASS
	CE	CODE
	CR	COLOR
	CC	COMBINATION CODE
	CN	COMPONENT
	CP	COMPOSITION
	CM	COMPOUND
	CD	CONDITION
	AV	CONFIGURATION
	CS	CONSTRUCTION
	BG	CORE CONDITION
	CB	CUT OFF
	AM	DELAY CLASS
	DE	DESIGN
	DG	DESIGNATOR
	DW	DRAWING NUMBER
	DU	DUPLEX
	EG	EDGE
	EN	END
	FY	FAMILY
	FG	FIGURE
	AK	FILE NUMBER
	FN	FINISH
	FB	FLAVOR
	BH	FLUX PERCENTAGE
	FM	FORM
	FA	FORMULA
	GR	GRADE
	GA	GRADUATION
	AX	GRANULES
	AY	GRIT
	GB	GROUND
	GP	GROUP
	HA	HEAVY DUTY
	BA	IMAGE COLOR
	NS	INSERT
	TM	ITEM
	KD	KIND
	KT	KIT
	LG	LENGTH
	LV	LEVEL
	LT	LIMIT
	MK	MARK
	AA	MARKER
	AD	MASK APERTURE
	ML	MATERIAL
	BB	MAXIMUM DENSITY
	TA	MEDIUM TEMPER
	MH	MESH
	ME	METHOD
	BC	MINIMUM DENSITY
	MD	MODEL
	MT	MOUNTING
	AQ	NATURAL
	AU	NON-DELAY CLASS
	NR	NUMBER
	BL	OUTFIT NUMBER
	PA	PARAGRAPH
	PT	PART
	PN	PATTERN
	PC	PHYSICAL CONDITION
	PS	PIECE
	PL	PLAN
	PR	POINT
	PD	POLISHED
	PB	PRESSURE RATING
	QA	QUALITY
	QB	QUENCHED
	RN	RANGE
	AE	RAPID
	RT	RATING
	RF	REFERENCE NUMBER
	RA	REGULAR DUTY
	BJ	RMA FLUX
	SJ	SALIENT CHARACTERISTICS
	SC	SCHEDULE
	SB	SECTION
	SL	SELECTION
	BD	SERIALIZED
	SE	SERIES
	SV	SERVICE
	SX	SET
	SA	SHADE
	SH	SHAPE
	SG	SHEET
	SZ	SIZE
	AG	SLOW
	TC	SOFT TEMPER
	SK	SOURCE
	PZ	SPECIES
	SQ	SPECIFICATION SHEET
	SD	SPEED
	AW	STANDARD
	SR	STRAIGHT
	ST	STYLE
	SS	SUBCLASS
	SF	SUBFORM
	SP	SUBTYPE
	BK	SUPPORT
	SN	SURFACE CONDITION
	SY	SYMBOL
	SM	SYSTEM
	TB	TABLE
	TN	TANNAGE
	TP	TEMPER
	TX	TEXTURE
	TK	THICKNESS
	TT	TREATMENT
	TR	TRIM
	TY	TYPE
	YN	UNIT
	AZ	UNSERIALIZED
	VA	VARIETY
	WT	WEIGHT
	WD	WIDTH

ZZZY*GREFERENCE NUMBER DIFFERENTIATING CHARACTERISTICS

A FEATURE OF THE ITEM OF SUPPLY WHICH MUST BE SPECIFICALLY RECORDED WHEN THE REFERENCE NUMBER COVERS A RANGE OF ITEMS.

Enter the reply in clear text.

(ZZZYGCOLOR CODED LEADS*; ZZZYGAS DIFFERENTIATED BY MATERIAL*)

AJCN*DPROTECTIVE STORAGE FEATURE

THE PECULIAR STORAGE FEATURE/S/ REQUIRED FOR AN ITEM IN ORDER TO PROVIDE THE DEGREE OF PROTECTION NECESSARY TO MAINTAIN SERVICEABILITY STANDARDS.

Enter the applicable reply code from the table below

(AJCNDAHX*;AJCNDAGS$DAFX*;AJCNDAGS$$DAFX*)

Table 1
	Reply Code (AA65)	Reply
	AFY	ANTINEOPLASTIC DRUG
	AHY	CONTROLLED ROOM TEMPERATURE
	AFX	EXPIRATION DATED
	AGS	FROZEN FOR PRESERVATION
	AHX	REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS
	AHQ	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
	AGV	SECURITY STORAGE
	AGW	SUBJECT TO DAMAGE BY FREEZING
	AGX	VAULT STORAGE

THPE*ATHERAPEUTIC EQUIVALENT

AN INDICATION OF THE SAME PREDICTABLE THERAPEUTIC EFFECT AS DETERMINED BY THE FOOD AND DRUG ADMINISTRATION (FDA) FOR AN ITEM OF SUPPLY WHEN ADMINISTERED UNDER THE CONDITIONS AS SPECIFIED IN THE LABELING.

Enter the alpha-numeric reply with a minimum of one character.

(THPEAJ7)

SUPP*GSUPPLEMENTARY FEATURES

CHARACTERISTICS OR QUALITIES OF AN ITEM NOT COVERED IN ANY OTHER REQUIREMENT THAT ARE CONSIDERED ESSENTIAL INFORMATION FOR ONE OR MORE FUNCTIONS, EXCLUDING NSN ASSIGNMENT.

Enter the reply in clear text.Separate multiple replies with a semicolon.

(SUPPGMAY INCL HOLE IN UPPER SUPPORT FOR MTG DURING SHIPMENT* SUPPGMAY INCL HOLE IN UPPER SUPPORT FOR MTG DURING SHIPMENT; BLADE TIEDOWN*)

Reply to this requirement only if the header record for the item identification for the item being identified has been coded as critical.

CRTL*ACRITICALITY CODE JUSTIFICATION

THE MASTER REQUIREMENT CODES OF THOSE REQUIREMENTS WHICH ARE TECHNICALLY CRITICAL BY REASON OF TOLERANCE,FIT,PERFORMANCE,OR OTHER CHARACTERISTICS WHICH AFFECT IDENTIFICATION OF THE ITEM.

Enter the Master Requirement Code for the requirement, the reply to which renders the item as being critical.

(CRTLAAKJA*; CRTLAAKJA$$ACSGS*)

If document availability code B, D, F, OR H, reply to MRC PRPY.

PRPY*APROPRIETARY CHARACTERISTICS

IDENTIFICATION OF THOSE CHARACTERISTICS INCLUDED IN THE DESCRIPTION FOR WHICH A NON-GOVERNMENT ACTIVITY HAS IDENTIFIED ALL OR SELECTED CHARACTERISTICS OF THE ITEM AS BEING PROPRIETARY AND THEREFORE RESTRICTED FROM RELEASE OUTSIDE THE GOVERNMENT WITHOUT PRIOR PERMISSION OF THE ORIGINATOR OF THE DATA.

Enter the MRC codes of the individual characteristics of the description which are marked proprietary on the technical data, using and coding ($) for multiple characteristics. If all the MRCS are proprietary, enter the reply PACS. If none of the MRCS is proprietary, enter the reply NPAC.

(PRPYAPACS*;PRPYANPAC*; PRPYAMATL$$ASURF*)

Reply to this MRC in accordance with Volume 3.

AGAV*GEND ITEM IDENTIFICATION

THE NATIONAL STOCK NUMBER OR THE IDENTIFICATION INFORMATION OF THE END EQUIPMENT FOR WHICH THE ITEM IS A PART.

Enter the reply in clear text.

(AGAVG3930-00-000-0000*; AGAVGFORKLIFT TRUCK, SMITH CORPORATION, MODEL 12, TYPE A*)

CRYC*DCONTROLLED SUBSTANCE CLASSIFICATION

DRUGS OR SUBSTANCES SUBJECT TO THE PROVISIONS OF THE COMPREHENSIVE DRUG ABUSE PREVENTION AND CONTROL ACT OF 1970.

Enter the applicable reply code from the table below

(CRYCDE)

Table 1
	Reply Code (AP11)	Reply
	B	SCHEDULE II
	C	SCHEDULE III
	D	SCHEDULE IV
	E	SCHEDULE V

AJUC*AAMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER

AN INDICATION OF THE AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER OF THE ITEM.

Enter the numeric reply with six digit(s) exactly.

(AJUCA111111)

AKJA*JACTIVE MEDICAMENT MEDICINAL STRENGTH

THE INGREDIENTS COMPOUNDED IN A PHARMACEUTICAL PREPARATION AND RECOGNIZED AS HAVING THERAPEUTIC VALUE/S/. /USUALLY REPRESENTATIVE IN THE ITEM NAME GENERIC NOMENCLATURE./

Enter the applicable Reply Code from Tables 1 & 2 & 3 below followed by a numeric reply with a minimum of one digit, a decimal and a minimum of one digit.

(AKJAJAJB4492BK2.0*)

Table 1
	Reply Code (AG53)	Reply
	AM	INTERNATIONAL UNITS
	AQ	PERCENT
	AA	PERCENTAGE
	AJ	UNITS
	AK	USP UNITS

Table 2
	Reply Code (AG54)	Reply
	B4492	CAMPHER
	B4493	EUKALYPTUSOEL
	B4494	KIEFERNNADELOEL

Table 3
	Reply Code (AG55)	Reply
	BN	PER FLUID OUNCE
	BK	PER GRAM
	BL	PER MILLIGRAM
	BY	PER MILLILITER
	CP	PER OUNCE
	BU	PERCENT

AKJQ*DPHARMACEUTICAL VEHICLE TYPE

THE LIQUID NONTOXIC COMPONENT FORM OF A PHARMACUETICAL PREPARATION WHICH NORMALLY HAS NO THERAPEUTIC ACTION,AND PRESENTS THE ACTIVE INGREDIENTS TO THE BODY FOR ABSORPTION.

Enter the applicable reply code from the table below

(AKJQDAH)

Table 1
	Reply Code (AG63)	Reply
	AD	ALCOHOL
	AP	ALCOHOLIC
	AA	ANHYDROUS GLYCEROL
	AB	AQUEOUS
	AE	AROMATIC NAPHTHA
	BA	CARBOXYMETHYLCELLULOSE
	BK	CELLULOSE MICROCRYSTALLINE
	BD	CENTRIFUGED WHOLE BLOOD AND URINE
	AQ	COLLODION BASE
	BL	CORNSTARCH
	BE	CRUDE OILS
	AF	DIETHYLENE GLYCOL
	BJ	ETHANOL
	AR	FLUORINATED HYDROCARBON
	BH	FORMAL GLYCEROL
	BF	GAS AND AIR PARTICLES
	AS	GLYCERIN
	AT	HYDROALCOHOLIC
	AG	ISOPROPANOL
	BR	LACTOSE MONOHYDRATE
	BP	MAGNESIUM STEARATE
	AW	MINERAL OIL
	AH	NAPHTHA
	AC	NONAQUEOUS
	AJ	NONTOXIC, FAST DRYING
	AN	OIL
	BB	OIL IN WATER EMULSION
	AK	PETROLEUM NAPHTHA
	AX	POLYGLYCOL
	BM	POVIDONE
	AY	PROPYLENE GLYCOL
	BG	REFINED OILS
	BC	SESAME OIL
	BQ	SODIUM HYDROGENCARBONATE
	BN	SODIUM LAURYL SULFATE
	AZ	VEGETABLE OIL
	AL	VOLATILE FLUORINE COMPOUND
	AM	WATER

CXCQ*DFIELD OF INDICATION

THE FIELD OF INDICATION WHICH APPLIES TO THE DIAGNOSIS.

Enter the applicable reply code from the table below

(CXCQDABT)

Table 1
	Reply Code (AP73)	Reply
	AAB	ADENOHYPOPHYSIAL HORMONES
	AAC	ALDOSTERONE ANTAGONISTS
	AAD	ANABOLICS
	AAE	ANALEPTICS
	AAF	ANALGETICS/ANTIRHEUMATICS
	AAG	ANDROGENS
	AAH	ANESTHETICS
	AAJ	ANTHELMINTICS
	AAK	ANTIALLERGIC DRUGS
	AAL	ANTIANDROGENS
	AAM	ANTIANEMIC DRUGS
	AAN	ANTIARRHYTHMICS
	AAP	ANTIARTHRITICS
	AAQ	ANTIBIOTICS/CHEMOTHERAPEUTICS
	AAR	ANTICARIES AND ANTIPARODONTOSIS DRUGS
	AAS	ANTICOAGULANTS
	AAT	ANTIDIABETICS
	AAU	ANTIDOTES
	AAV	ANTIEMETICS/ANTIVERTIGINOUS DRUGS
	AAW	ANTIEPILEPTICS
	AAX	ANTIESTROGENS
	AAY	ANTIFIBRINOLYTICS
	AAZ	ANTIGRIPPAL DRUGS
	ABA	ANTIHEMORRHOIDAL DRUGS
	ABB	ANTIMYCOTICS
	ABC	ANTIPARASITIC DRUGS
	ABD	ANTIPHLOGISTICS
	ABE	ANTITUSSIVES
	ABF	ANTIVARICOSE DRUGS
	ABG	ARTERIOSCLEROSIS DRUGS
	ABH	BALNEOLOGIC THERAPEUTICS
	ABJ	BETA RECEPTORS BLOCKING PHARMACA
	ABK	BIOLOGICAL MATERIALS/MEDICAL PLASTICS
	ABL	BLOOD FLOW STIMULATING DRUGS
	ABM	BRONCHOLYTICS/ANTIASTHMATICS
	ABN	CALCIUM ANTAGONISTS
	ABP	CARDIAC DRUGS
	ABQ	CATHARTIC DRUGS
	ABR	CHOLAGOGUE DRUGS AND BILIARY TRACT THERAPEUTICS
	ABS	CHOLINERGICS
	ABT	CONTRACEPTIVES
	ABU	CORONARY DRUGS
	ABV	CORTICOIDS
	ABW	CYSTOSTATICS AND METASTASIS INHIBITORS
	ABX	DENTAL THERAPEUTICS
	ABY	DERMATICS
	ABZ	DIAGNOSTIC DRUGS
	ACA	DIETETIC DRUGS/NUTRITIVE THERAPEUTICS
	ACB	DISACCUSTOMING DRUGS
	ACC	DISINFECTANT DRUGS/ANTISEPTICS
	ACD	DIURETIC DRUGS
	ACE	EMACIATION DRUGS
	ACF	ENZYME INHIBITORS
	ACG	ENZYME PREPARATIONS
	ACH	ESTROGENS
	ACJ	EXPECTORANT DRUGS
	ACK	FIBRINOLYTIC DRUGS
	ACL	GASTROINTESTINAL DRUGS
	ACM	GERIATRIC DRUGS
	ACN	GESTANGENES
	ACP	GYNECOLOGICS
	ACQ	HEMOSTYPTIC DRUGS/ANTIHAEMORRHAGICS
	ACR	HOMEOPATHIC DRUGS
	ACS	HYPNOTIC DRUGS/SEDATIVES
	ACT	HYPOPHYSIAL HORMONES/HYPOTHALAMIC HORMONES
	ACU	HYPOTENSORS
	ACV	HYPOTHALAMIC HORMONES
	ACW	IMMUNOSTIMULATING DRUGS
	ACX	IMMUNOSUPPRESSIVES
	ACY	INFUSION AND COMBINED SOLUTIONS
	ACZ	INFUSION AND COMBINED SOLUTIONS FOR PARENTERAL FEEDING
	ADA	INFUSION AND COMBINED SOLUTIONS FOR VOLUME REPLACEMENT AND/OR THERAPY OF MICROCIRCULATION DISTURBANCES
	ADB	INFUSION AND STANDARD INJECTION SOLUTIONS
	ADC	INFUSION SOLUTIONS FOR ELECTROLYTE SUPPLY
	ADE	INFUSION SOLUTIONS FOR ENERGY SUPPLY
	ADF	INFUSION SOLUTIONS FOR SUPPLY OF AMINO ACIDS
	ADG	INFUSION SOLUTIONS FOR SUPPLY OF PROTEIN HYDROLYSATES
	ADH	LIPID LOWERING DRUGS
	ADJ	LOCAL ANESTHETICS EXTERNAL
	ADK	LOCAL ANESTHETICS INTERNAL
	ADL	MINERAL PREPARATIONS
	ADM	MUSCLE RELAXANTS
	ADN	NEURAL THERAPEUTICS
	ADP	NEUROHYPOPHYSIAL HORMONES
	ADQ	OPHTHALMIC DRUGS
	ADR	OROPHARYNGEAL THERAPEUTICS
	ADS	OTIC DRUGS
	ADT	PARKINSON DRUGS AND ANTIHYPERKINETICS
	ADU	PSYCHOCHEMICALS
	ADV	RHINAL DRUGS
	ADW	SERA AND VACCINES
	ADX	SPASMOLYTICS
	ADY	SULFONAMIDES AND OTHER CHEMOTHERAPEUTICS
	ADZ	THYROID THERAPEUTICS
	AEA	TUBERCULOSIS DRUGS
	AEB	UROLOGIC DRUGS
	AEC	VITAMINS
	AED	WOUND TREATMENT DRUGS

ELRN*GEXTRA LONG REFERENCE NUMBER

A REFERENCE NUMBER EXCEEDING 32 POSITIONS.

Enter the entire reference number. Do not include the 5-position Commercial and Government Entity (CAGE) Code unless there is more than one extra long reference number on the NSN.If there is more than one extra long reference number on the NSN, include the CAGE or NCAGE and separate each reference by using the "&" character.

(e.g., CAGE112036BIL060557LEN313605UZ62365 & CAGE112036BIL060557LEN313605UZ62365)

In determining quantity of characters in the reference number, count will be made after modification in accordance with Volume 2, Chapter 9, FLIS Procedures Manual, DoD 4100.39-M.

CXCY*GPART NAME ASSIGNED BY CONTROLLING AGENCY

THE NAME ASSIGNED TO THE ITEM BY THE GOVERNMENT AGENCY OR COMMERCIAL ORGANIZATION CONTROLLING THE DESIGN OF THE ITEM.

Enter the reply in clear text.

(CXCYGLINE PROCESSOR CONTROL BOARD*)

CLQL*GCOLLOQUIAL NAME

A COMMON USAGE NAME BY WHICH AN ITEM IS KNOWN.

Enter the reply in clear text.

(CLQLGWOVEN WIRE CLOTH*)